Related to Sigma Life Science Gains Rights to iPSC Technology from iPS Academia Japan

• Horizon and University of Washington Partner to Apply Gene Editing to IPSCs
  
• Genetic Abnormalities Found in Pluripotent Stem Cell Lines
  
• BioTime Buys Assets from Cell Targeting to Boost Its Regenerative Medicine Focus
  
• Sigma-Aldrich Takes Over Resource Technology to Expand Analytical Suite
  
• Researchers Identify miRNAs Involved in Cellular Reprogramming
  
• Cedars-Sinai Team Wins $1.9M to Develop iPSC System for Testing Compounds against SMA
  
• Univercell Licenses iPS Academia Technology to Generate iPSC-Derived Cardiomyocytes
  
• CDI to Supply iPSC-Derived Human Heart Cells for Roche's Drug Development Efforts
  
• Researchers Find Extended Culturing of Engineered iPSCs Doesn’t Increase Mutations
  
• Ectycell and Caisse des Depots Pledge €12M for Development of Industrial iPSC Platform
  
• Scientists Use miRNAs to Improve Efficiency of Generating iPSCs Without Transcription Factors
  
• Cellular Dynamics International Closes $30M Series B Preferred Stock Round
  
• Researchers Describe Virus-Free Method for Generating Beating Myocardiocytes from iPSCs
  
• Researchers Generate Transplantable Photoreceptors from Swine iPSCs
  
• Cellular Dynamics Taps ViaCyte’s Definitive Endoderm Differentiation Technology
  
• Researchers Find iPSCs Have Same Capacity as ESCs to Differentiate Into Endodermal Cell Types
  
• Liver Cells from Human iPSCs Found to Engraft and Function as Efficiently as Primary Hepatocytes
  
• Scientists Find iPSCs Trigger Immune Rejection Reactions Due To Gene Overexpression
  
• Studies Suggest Not All iPSC-Derived Neural Precursor Cells Are Created Equal
  
• Researchers Figure Out How to Selectively Correct Mutations in Patient-Derived Human iPSCs